Previous close | 39.07 |
Open | 39.63 |
Bid | 39.72 x 2200 |
Ask | 40.00 x 800 |
Day's range | 39.59 - 40.12 |
52-week range | 33.67 - 45.93 |
Volume | |
Avg. volume | 3,606,919 |
Market cap | 81.277B |
Beta (5Y monthly) | 0.30 |
PE ratio (TTM) | 14.19 |
EPS (TTM) | 2.81 |
Earnings date | 31 Jul 2024 |
Forward dividend & yield | 1.49 (3.74%) |
Ex-dividend date | 16 May 2024 |
1y target est | 45.80 |
Glaxo (GSK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Around 3,000 of the drug giant’s staff will be based at The Earnshaw building on the corner of New Oxford Street.
PHILADELPHIA, July 11, 2024--GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its trivalent influenza vaccines to US healthcare providers and pharmacies in preparation for the 2024-25 flu season. This immediately follows a licensing and lot-release approval from the US Food and Drug Administration (FDA).